5-(4-chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine
- $252 - $904
- Product name: 5-(4-chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine
- CAS: 35317-61-4
- MF: C10H10ClN3S
- MW: 239.72
- EINECS:
- MDL Number:MFCD01821400
- Synonyms:5-(4-chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine;[5-(4-chloro-phenyl)-[1,3,4]thiadiazol-2-yl]-ethyl-amine;1,3,4-Thiadiazol-2-amine, 5-(4-chlorophenyl)-N-ethyl-
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 5MG
- 500mg
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0180429
- Product description5-(4-CHLOROPHENYL)-N-ETHYL-1,3,4-THIADIAZOL-2-AMINE 95.00%
- Packaging5MG
- Price$497.4
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11137485
- Product description5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine 97%
- Packaging5g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11137485
- Product description5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine 97%
- Packaging1g
- Price$320
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number039903
- Product description5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0180429 | 5-(4-CHLOROPHENYL)-N-ETHYL-1,3,4-THIADIAZOL-2-AMINE 95.00% | 5MG | $497.4 | 2021-12-16 | Buy |
Crysdot | CD11137485 | 5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine 97% | 5g | $904 | 2021-12-16 | Buy |
Crysdot | CD11137485 | 5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine 97% | 1g | $320 | 2021-12-16 | Buy |
Matrix Scientific | 039903 | 5-(4-Chlorophenyl)-N-ethyl-1,3,4-thiadiazol-2-amine | 500mg | $252 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|